Comparison of different phenotypic assays for the detection of extended-spectrum β-lactamase production by inducible AmpC-producing Gram-negative bacilli

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 4, 2013, Pages 549-555

  Willems, E ^a   Cartuyvels, R ^b   Magerman, K ^b   Raymaekers, M ^b   Verhaegen, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b JESSA HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE AMPC; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CLOXACILLIN;

AGAR MEDIUM; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CITROBACTER FREUNDII; CONTROLLED STUDY; DISK DIFFUSION; DOUBLE DISK SYNERGY TEST; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENZYME ASSAY; ENZYME SYNTHESIS; EPSILOMETER TEST; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; INTERMETHOD COMPARISON; MORGANELLA MORGANII; MUELLER HINTON AGAR; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROVIDENCIA; SENSITIVITY AND SPECIFICITY; SERRATIA MARCESCENS; TEST STRIP;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CULTURE MEDIA; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84879463433     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1772-x     Document Type: Article

References (17)

1. [No authors listed] (2002) The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa on length of hospital stay. Infect Control Hosp Epidemiol 23:106-108
2. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001) Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32:1162-1171 (Pubitemid 32390110)
3. Cantón R, Coque TM (2006) The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 9(5):466-475 (Pubitemid 44397640)
4. Pfaller MA, Segreti J (2006) Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Clin Infect Dis 42(Suppl 4):S153-S163
5. Ramphal R, Ambrose PG (2006) Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis 42(Suppl 4):S164-S172
6. Garrec H, Drieux-Rouzet L, Golmard JL, Jarlier V, Robert J (2011) Comparison of nine phenotypic methods for detection of extended-spectrum β-lactamase production by Enterobacteriaceae. J Clin Microbiol 49(3):1048-1057
7. Wiegand I, Geiss HK, Mack D, Stürenburg E, Seifert H (2007) Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol 45:1167-1174 (Pubitemid 46626480)
8. Harada S, Ishii Y, Yamaguchi K (2008) Extended-spectrum β-lactamases: implications for the clinical laboratory and therapy. Korean J Lab Med 28:401-412
9. Jiang X, Zhang Z, Li M, Zhou D, Ruan F, Lu Y (2006) Detection of extended-spectrum β-lactamases in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 50(9):2990-2995 (Pubitemid 44396403)
10. Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A (2000) Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol 38(2):542-546 (Pubitemid 30082638)
11. Drieux L, Brossier F, Sougakoff W, Jarlier V (2008) Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. European Society of Clinical Microbiology and Infectious Diseases. J Clin Microbiol Infect 14(Suppl 1):90-103 (Pubitemid 350269190)
12. Towne TG, Lewis JS 2nd, Herrera M, Wickes B, Jorgensen JH (2010) Detection of SHV-type extended-spectrum beta-lactamase in Enterobacter isolates. J Clin Microbiol 48(1):298-299
13. Stürenburg E, Sobottka I, Noor D, Laufs R, Mack D (2004) Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection. J Antimicrob Chemother 54(1):134-138 (Pubitemid 39028980)
14. Mohanty S, Gaind R, Ranjan R, Deb M (2009) Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria. J Infect Dev Ctries 4(1):24-29
15. Stuart JC, Diederen B, Al Naiemi N, Fluit A, Arents N, Thijsen S, Vlaminckx B, Mouton JW, Leverstein-van Hall M (2011) Method for phenotypic detection of extended-spectrum beta-lactamases in Enterobacter species in the routine clinical setting. J Clin Microbiol 49(7):2711-2713
16. Clinical and Laboratory Standards Institute (CLSI) (2011) Performance standards for antimicrobial susceptibility testing; Twenty-first informational supplement. CLSI document M100-S21. CLSI, Wayne
17. Check-MDR CT101. User manual, version 1.1, issued October 1, 2010. Check-Points Health BV, Wageningen, the Netherlands